Trademarkia Logo

Canada

C$
Trademark Search in Canada
XERIJECT

View On IC.GC.CA

XERIJECT
SEARCHED

on 9 Dec 2022

Last Applicant/ Owned by

Xeris Pharmaceuticals, Inc.

180 N LaSalle Street, Suite 1810Chicago IL 60601

US

Serial Number

2128132 filed on 3rd Jun 2021

Correspondent Address

NORTON ROSE FULBRIGHT CANADA LLP/S.E.N.C.R.L.,S.R.L.

3700 CANTERRA TOWER400 - THIRD AVENUE S.W.CALGARY

ALBERTA

CA

T2P4H2

XERIJECT

Trademark usage description

pharmaceutical research and development; pharmaceutical drug formulation and development services; providing information on drug technology platforms Read More

Classification Information

Class [005]
Pharmaceuticals and herbicides

Comment text

CIPO Classification Code

Classification kind code

Nice

Class [042]
Pharmaceutical research and development; pharmaceutical drug formulation and development services; providing information on drug technology platforms for the formulation and development of drugs and biologics.

Classification kind code

11

Mark Details

Serial Number

2128132

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 48
on 6th Mar 2023		Agent Changed
Submitted for opposition 22
on 9th Dec 2022		Search Recorded
Submitted for opposition 20
on 9th Dec 2022		Examiner's First Report
Submitted for opposition 223
on 9th Dec 2022		Total Provisional Refusal
Submitted for opposition 256
on 20th Jun 2022		Notification of Possible Opposition Sent
Submitted for opposition 257
on 19th Aug 2021		Designation Notification - Madrid Protocol
Submitted for opposition 31
on 19th Aug 2021		Formalized
Submitted for opposition 1
on 19th Aug 2021		Created
Submitted for opposition 228
on 3rd Jun 2021		International Registration
Submitted for opposition 30
on 3rd Jun 2021		Filed